Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Equity Ratio (2016 - 2025)

Dare Bioscience (DARE) has disclosed Equity Ratio for 11 consecutive years, with 0.09 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 213.07% year-over-year to 0.09, compared with a TTM value of 0.09 through Sep 2025, up 213.07%, and an annual FY2024 reading of 0.27, down 14.69% over the prior year.
  • Equity Ratio was 0.09 for Q3 2025 at Dare Bioscience, up from 0.98 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.69 in Q4 2021 and bottomed at 0.98 in Q2 2025.
  • Average Equity Ratio over 5 years is 0.08, with a median of 0.11 recorded in 2024.
  • The sharpest move saw Equity Ratio surged 1338.57% in 2021, then plummeted 966.86% in 2025.
  • Year by year, Equity Ratio stood at 0.69 in 2021, then crashed by 63.49% to 0.25 in 2022, then crashed by 193.54% to 0.24 in 2023, then fell by 14.69% to 0.27 in 2024, then skyrocketed by 134.17% to 0.09 in 2025.
  • Business Quant data shows Equity Ratio for DARE at 0.09 in Q3 2025, 0.98 in Q2 2025, and 0.51 in Q1 2025.